Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Gemtuzumab ozogamicin |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing infliximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing monoclonal antibody (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monoclonal antibody |
Inferred relationship |
Some |
1 |
Product containing abciximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing daclizumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing basiliximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing etanercept (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
abciximab 2 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing trastuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Trastuzumab 150 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
monoklonalt antistof fra mus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
muromonab-CD3 1 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
murin-humant monoklonalt IgG-antistof |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Infliximab 100mg powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
etanercept 25 mg pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Abciximab 10mg/5 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Etanercept 25mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Trastuzumab 440 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Daclizumab 25mg/5 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Basiliximab 20mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Infliximab 100mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing ibritumomab tiuxetan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Palivizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Rituximab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing alemtuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Alemtuzumab 30mg/3mL infusion concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Escherichia coli monoklonalt antistof |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Canine lymphoma monoclonal antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing adalimumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Infliximab 100 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Omalizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Efalizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Tositumomab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
daclizumab 25 mg/5 ml koncentrat til infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
basiliximab 20 mg injektionsvæske (pulver til rekonstitution) + solvens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
basiliximab 10 mg injektionsvæske (pulver til rekonstitution) + solvens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
adalimumab 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
alemtuzumab 30 mg/3 ml koncentrat til infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Infliximab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing cetuximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
cetuximab 2 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing bevacizumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 4 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ibritumomab tiuxetan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
ibritumomab tiuxetan 1,6 mg/ml radiofarmaceutisk infusionssæt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing muromonab-CD3 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Natalizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Etanercept 25mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
alemtuzumab 30 mg/ml koncentrat til infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
monoklonalt antistof-agens |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Iodine (124-I) labeled monoclonal antibody (substance) |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Panitumumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
murin-humant monoklonalt IgG-antistof |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
monoklonalt antistof fra mus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing ustekinumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Belimumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Besilesomab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Brentuximab vedotin (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Alirocumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Idarucizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Necitumumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Daratumumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Blinatumomab (substance) |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Olaratumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Bezlotoxumab (substance) |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Dinutuximab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ixekizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Obiltoxaximab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Raxibacumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Brodalumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Avelumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ocrelizumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Dupilumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Muromonab-CD3 |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
murin-humant monoklonalt IgG-antistof |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ibritumomab tiuxetan (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Adalimumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Bevacizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ranibizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Eculizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Zanolimumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Oregovomab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Certolizumab pegol (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Naptumomab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Golimumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ustekinumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Tocilizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Denosumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Canakinumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Nivolumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Pertuzumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Vedolizumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ramucirumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Siltuximab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Secukinumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Obinutuzumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Catumaxomab |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Elotuzumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|